Thomas S. Hall - Chairman

Thomas S. Hall has served as President and Chief Executive Officer of NovaMed Inc., and has been a member of our Board of Directors, since November 14, 2005. Mr. Hall was appointed Chairman of the Board on February 21, 2007.

From April 2003 to November 2005, Mr. Hall served as President and Chief Operating Officer of Matria Healthcare, Inc., after having joined Matria in October 2002 as Executive Vice President and Chief Operating Officer. Matria provides disease management programs to health plans and employers.

From 2000 to 2002, Mr. Hall was President and Chief Executive Officer of TSH & Associates, an independent consulting and management services company. From 1997 to 1999, Mr. Hall held several executive positions that included President of ADP TotalSource, a division of Automated Data Processing, Inc. (ADP). Mr. Hall also served in senior management positions with Riscorp, Inc., an insurance holding company, and USAir Express/Chautauqua Airlines.

A native of Upstate New York, Mr. Hall earned a BA in business from Goshen College and an MBA from Clarkson University.

Robert J. Kelly joined NovaMed's Board of Directors in April 2004, served as non-executive Chairman from October 2005 until he was appointed Lead Director in February 2007. He has spent over 30 years in finance and general management and is currently an independent consultant. From 2000 to 2001, Mr. Kelly served as Executive Vice President and Chief Financial Officer of Celarix, Inc., a company that provides enterprise level solutions of logistics over the Internet. From 1997 to 2000, Mr. Kelly served as Chief Financial Officer of Summit Autonomous, Inc., a manufacturer of excimer lasers that was acquired by Alcon Laboratories, Inc. in 2000. Previously, from 1992 to 1997, Mr. Kelly served as Chief Financial Officer of Bull HN Information Systems, Inc., the U.S. subsidiary of Groupe Bull, an international information technology company based in France.

A native of Massachusetts, Mr. Kelly holds a BS in Mathematics from the University of Massachusetts and a MBA from the Harvard Business School.

R. Judd Jessup - Board Member

R. Judd Jessup has been a member of NovaMed's Board of Directors since November 1998. He is currently CEO of US Labs, an anatomic pathology laboratory primarily providing services related to the diagnosis and treatment of cancer. From 1994 to 1996 he served as President of the HMO Division of FHP International Corporation, a diversified health care services company.

From 1987 to 1994, Mr. Jessup served as President of Take Care, Inc., a multi-state HMO which was acquired by FHP International Corporation in 1994.

In addition to NovaMed, Mr. Jessup presently serves on the Board of Directors for Corvel Corporation, a publicly held workers compensation utilization management company; Pacific Dental Benefits, a dental HMO; and US Labs.

A native of California, Mr. Jessup received his BA from Knox College in Illinois and a MBA from University of Denver.

Scott H. Kirk, M.D. - Board Member

Scott H. Kirk, M.D. has been a member of NovaMed's Board of Directors since August 1995. Dr. Kirk has practiced ophthalmology in the Chicago area since 1982, and has been the Medical Director at SureVision Eye Centers in River Forest, Illinois since 1987.

Dr. Kirk is an assistant clinical professor at the University of Illinois and is on the medical staff at West Suburban Hospital, Oak Park Hospital and Gottleib Memorial Hospital.

Dr. Kirk is certified by the American Board of Ophthalmology and is a Fellow of the American Academy of Ophthalmology. Dr. Kirk is also a director of the Outpatient Ophthalmology Surgical Society.

Dr. Kirk earned his M.D. from Washington University Medical School in 1978 and completed his residency there in 1982.

Steven V. Napolitano - Board Member

Mr. Napolitano has served as a member of NovaMed’s Board of Directors since January 1997.  Since September 2007, he has been a partner and co-chair of DLA Piper US Private Equity practice.  He also serves on the firm wide Policy Committee.  Prior to that, he was a partner and co-chair of the Private Equity practice of the law firm of Winston and Strawn LLP. 

Mr. Napolitano has also served as a senior partner in the law firm of Katten Muchin Rosenman, LLP and has practiced law in the Chicago offices of Dickinson, Wright, Moon, Van Dusen & Freeman and Kirkland & Ellis.

He earned his B.A. in Economics from the University of Notre Dame in 1981, and his J.D. from the Boston University School of Law as a G. Joseph Tauro Scholar in 1985.

C.A. Lance Piccolo - Board Member

C.A. Lance Piccolo has been a member of NovaMed's Board of Directors since 2000. Mr. Piccolo was Chairman and Chief Executive Officer of Caremark International, Inc. from 1992 through 1996, following its spin-off from Baxter International, Inc. Mr. Piccolo continues to serve as Vice Chairman of Caremark Rx, Inc. (NYSE: CMX), a leading prescription benefits management firm.

Over Mr. Piccolo's distinguished 25-year career at Baxter, he progressed through a series of sales, operating and executive positions, including Executive Vice President for over five years. He was responsible for Baxter's alternate site operations and oversaw its development into one of the industry leaders. He was also a member of Baxter's Board of Directors from 1988 through 1992.

Since 1996, Mr. Piccolo has served as President and Chief Executive Officer of HealthPic Consultants, Inc., a strategic health care consulting firm. Additionally, he serves on the Board of Directors of Crompton Corporation (NYSE: CK), Physician Dynamics, Inc., Benchmark Medical, Inc., Wind Point Partners, National Nephrology Associates, Inc., MedAssets Advisory Board and Lake Forest Hospital Foundation. He is also a member of the board of trustees of the University of Chicago Hospitals and the Advisory Board of Northwestern University, Kellogg Graduate School of Management.